ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Up 167.7% in October

ENDRA Life Sciences Inc. (NASDAQ:NDRA) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 717,700 shares, an increase of 167.7% from the September 30th total of 268,100 shares. Approximately 4.0% of the company’s stock are short sold. Based on an average daily trading volume, of 9,790,000 shares, the days-to-cover ratio is presently 0.1 days.

ENDRA Life Sciences Stock Performance

NDRA remained flat at $0.28 during trading on Monday. 3,025,131 shares of the company’s stock were exchanged, compared to its average volume of 21,143,144. The stock has a 50-day moving average of $0.28 and a two-hundred day moving average of $276.24. ENDRA Life Sciences has a 12 month low of $0.18 and a 12 month high of $139.50.

ENDRA Life Sciences (NASDAQ:NDRA) last posted its earnings results on Wednesday, August 14th. The company reported ($4.00) EPS for the quarter, missing the consensus estimate of ($3.50) by ($0.50). As a group, analysts predict that ENDRA Life Sciences will post -11.08 EPS for the current fiscal year.

About ENDRA Life Sciences

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.